Cancer Drug Profit Margins Rise to 700%, Up From 30% in 2019
A news headline says cancer drug profit margins were 30% in 2019 and are now 700%. The headline gives no further detail on who earns these margins or how they were calculated.
Context
Context: Margin means the gap between what a drug costs to make or buy and what it sells for. Cancer treatment is expensive in India, and drug prices have been a long-running debate between companies, patients and regulators.
Burning Potato score: 72%